Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
出版年份 2023 全文链接
标题
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
作者
关键词
-
出版物
Lancet Rheumatology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-01-24
DOI
10.1016/s2665-9913(23)00006-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- OP0177 IMMUNOGENICITY INDUCED BY TWO AND THREE DOSES OF THE BNT162B2 mRNA VACCINE IN PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES AND IMMUNOCOMPETENT CONTROLS: A LONGITUDINAL MULTI-CENTER STUDY
- (2022) V. Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons
- (2022) Nischal Ranganath et al. CLINICAL INFECTIOUS DISEASES
- COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy
- (2022) J.M. Coulson et al. JOURNAL OF INFECTION
- DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
- (2022) Michael Di Iorio et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Breakthrough SARS‐CoV‐2 infections in immune mediated disease patients undergoing B cell depleting therapy: A retrospective cohort analysis
- (2022) Cassandra M Calabrese et al. Arthritis & Rheumatology
- Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022
- (2022) Deborah E. Malden et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19
- (2022) Annaliesa S. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rebound of SARS-CoV-2 Infection after Nirmatrelvir–Ritonavir Treatment
- (2022) Michael E. Charness et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of COVID ‐19 among unvaccinated and vaccinated patients with rheumatoid arthritis: a general population study
- (2022) Hui Li et al. ARTHRITIS CARE & RESEARCH
- Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity
- (2022) Cassandra Calabrese et al. RMD Open
- Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
- (2022) Michael DiIorio et al. RMD Open
- Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
- (2022) Gabriel Figueroa-Parra et al. Lancet Rheumatology
- Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
- (2021) Parakkal Deepak et al. ANNALS OF INTERNAL MEDICINE
- Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
- (2021) Jeffrey A Sparks et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
- (2021) Tiffany Y-T Hsu et al. Lancet Rheumatology
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- (2021) Robert L. Gottlieb et al. NEW ENGLAND JOURNAL OF MEDICINE
- REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
- (2021) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS‐CoV ‐2 Infection and COVID ‐19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta‐Analysis
- (2021) Richard Conway et al. Arthritis & Rheumatology
- Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
- (2021) Ingrid Jyssum et al. Lancet Rheumatology
- Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’
- (2020) Kristin M D’Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now